Monopar Therapeutics shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Monopar Therapeutics (MNPR) shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Monopar Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Monopar Therapeutics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Monopar Therapeutics by Jpmorgan Chase & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-06-30 | $237k | 2.5k | 94.56 |
| 2026-03-31 | $129k | 2.4k | 53.29 |
| 2025-09-30 | $122k | 1.5k | 81.67 |
| 2025-03-31 | $3.6k | 100 | 36.41 |
| 2024-12-31 | $45k | 2.0k | 22.00 |